Chemokine receptor CCR5 in interferon-treated multiple sclerosis
Research output: Contribution to journal › Journal article › Research
To study the relationship between CC chemokine receptor CCR5 expression and disease activity in multiple sclerosis (MS) patients treated with beta-interferon (IFN-beta).
| Original language | English |
|---|---|
| Journal | Acta Neurologica Scandinavica |
| Volume | 115 |
| Issue number | 6 |
| Pages (from-to) | 413-8 |
| Number of pages | 6 |
| ISSN | 0001-6314 |
| DOIs | |
| Publication status | Published - Jun 2007 |
- Adult, Biological Markers, Central Nervous System, DNA Mutational Analysis, Female, Gene Frequency, Genetic Markers, Genetic Predisposition to Disease, Genetic Testing, Genotype, Humans, Interferon-beta, Interferons, Male, Middle Aged, Monocytes, Multiple Sclerosis, Relapsing-Remitting, Mutation, Polymorphism, Genetic, Promoter Regions, Genetic, Receptors, CCR5
Research areas
ID: 111411554